Intuitive Surgical Stock Sinks to 52-Week Low - Here's Why

Intuitive Surgical Inc. (NASDAQ: ISRG ) stock fell sharply Friday after the company reaffirmed its 2026 da Vinci procedure growth outlook but flagged slowing U.S. procedure trends and insurance-related headwinds that weighed on investor sentiment.

The robotic surgery company said U.S. procedure growth moderated relative to recent trends and its expectations at the start of the year, driven mainly by procedures that patients can defer.

China Competition And International Headwinds During the earnings call, CEO David Rosa said the operating environment in China remains difficult. “In China, the environment remains challenging.

We continue to see lower tender activity, increased domestic robotic competition, and policy-driven pricing pressure.” Rosa added that the company continues to navigate policy changes, including charge code revisions and China’s 15th Five-Year Plan quota process. “We continue to operate through a dynamic policy environment, including charge code changes and the 15th Five-Year Plan quota process.

We are engaging with provincial governments on the charge code policy and are progressing through the green channel process for both SP and Da Vinci 5.

When cleared, these platforms will bring additional differentiated capabilities to Chinese customers and their patients.” In Japan, Rosa noted that new reimbursement policies supporting robotic surgery took effect on June 1, expanding coverage for additional procedures and providing incentives for higher utilization.

Read Also: FDA Flags Safety Concern Over Intuitive Surgical Stapler US Procedure Growth Slows Chief Financial Officer Jamie Samath said the expiration of enhanced Affordable Care Act premium subsidies affected some patients and contributed to softer procedure growth. “Patients impacted by the expiration of subsidies for ACA Enhanced premiums.

Looking at benign procedures, a subset of which can be deferred, we saw a slight moderation in procedure growth rate that started in Q1.

U.S. da Vinci Bariatric cases continued to feel the impact of rising GLP-1 usage, declining high single digits during the quarter.” Analysts Cut Price Forecasts William Blair said Intuitive Surgical’s more than 10% after-hours decline reflects elevated investor expectations rather than a deterioration in the company’s long-term outlook.

The brokerage said maintaining, rather than raising, its 2026 procedure growth guidance disappointed investors given the stock’s premium valuation.

It also flagged several near-term headwinds, including weaker Affordable Care Act-related procedure volumes, intensifying competition in China, slowing growth as the business scales, and pricing initiatives that could heighten competitive concerns.

William Blair said those factors may create uncertainty around earnings and limit upside over the next few quarters.

However, it maintained its Outperform rating, citing Intuitive Surgical’s industry-leading earnings growth profile.

The firm added that greater clarity on these issues, along with continued execution, could support the stock after several quarters.

Piper Sandler said U.S. procedure growth slowed by about 200 basis points sequentially and fell short of Wall Street expectations.

The firm also noted that maintaining full-year procedure growth guidance of 13.5% to 15.5% disappointed investors.

Analyst Adam Maeder reiterated an Overweight rating but lowered the price forecast to $470 from $580.

Several other Wall Street firms also reduced their price forecasts following the results.

JPMorgan lowered its target to $450 from $550, Mizuho to $400 from $500, Wells Fargo to $487 from $654, TD Cowen to $485 from $520, Evercore ISI to $375 from $430, RBC Capital to $575 from $600, Stifel to $550 from $670, Citigroup to $500 from $590, Bernstein to $685 from $750, Leerink Partners to $454 from $573, Baird to $500 from $525 and BTIG to $469 from $512.

Intuitive Surgical Price Action ISRG Price Action: Intuitive Surgical shares were down 13.14% at $349.45 at the time of publication on Friday.

The stock is trading at a new 52-week low, according to Pro data.

Image via Shutterstock Read Also: ConocoPhillips Taps Into Billion-Barrel Iraq Asset In Strategic BP Deal